Carl Gordon

Carl Gordon

Fortune : 57 960 $ au 31/10/2026

61 ans
Health Technology
Finance
Consumer Services

Profil

Dr. Carl L.
Gordon is an Independent Director at Electra Therapeutics, Inc., a Chairman at Compass Therapeutics, Inc., a Managing Partner at OrbiMed Advisors Private Equity, a Managing Partner at OrbiMed Advisors LLC, an Advisor at The New York City Investment Fund Manager, Inc., an Independent Director at Avenzo Therapeutics, Inc. /New/ and a Principal at Aragon Pharmaceuticals, Inc. He is on the Board of Directors at Lomond Therapeutics Holdings, Inc., Scribe Therapeutics, Inc., Blossomhill Therapeutics, Inc., ADARx Pharmaceuticals, Inc., Electra Therapeutics, Inc., Adimab LLC, Agensys, Inc., Amnis Corp., Emendo Biotherapeutics, Inc., Frontera Therapeutics (HK) Ltd., Gemini Therapeutics Sub, Inc., Gwynant Therapeutics, Inc., Kumquat Biosciences, Inc., Sapphire Therapeutics, Inc., Star OpCo, Inc., Stratus Therapeutics, Inc., X4 Pharmaceuticals (Austria) GmbH, XinThera, Inc. and Avenzo Therapeutics, Inc. /New/.
Dr. Gordon was previously employed as an Independent Director by Arrivent BioPharma, Inc., an Independent Director by MBX Biosciences, Inc., an Independent Director by Keros Therapeutics, Inc., an Independent Director by Kinnate Biopharma, Inc., an Independent Director by Terns Pharmaceuticals, Inc., an Independent Non-Executive Director by Passage Bio, Inc., an Independent Director by Theseus Pharmaceuticals, Inc., an Independent Director by Springworks Therapeutics, Inc., a Lead Independent Director by Turning Point Therapeutics, Inc., an Independent Director by Gemini Therapeutics, Inc., an Independent Director by Oric Pharmaceuticals, Inc., a Chairman by Adicet Bio, Inc., an Independent Director by Intellia Therapeutics, Inc., an Independent Director by Alector, Inc., an Independent Director by Arsanis, Inc., an Independent Director by Selecta Biosciences, Inc., an Independent Director by Complete Genomics, Inc., an Independent Non-Executive Director by Amarin Corp.
Plc, and an Independent Director by Pacira Pharmaceuticals, Inc.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
04/06/2025 5 250 ( 0,03 % ) 57 960 $ 31/10/2026
31/03/2026 0 ( -.--% ) - $ 31/10/2026
06/08/2026 0 ( -.--% ) - $ 31/10/2026

Postes actifs de Carl Gordon

SociétésPosteDébut
COMPASS THERAPEUTICS, INC. Président 01/01/2015
BLOSSOMHILL THERAPEUTICS, INC. Directeur/Membre du Conseil 01/02/2021
ELECTRA THERAPEUTICS, INC. Directeur/Membre du Conseil 01/03/2019
SCRIBE THERAPEUTICS INC. Directeur/Membre du Conseil 01/03/2021
ADARX PHARMACEUTICALS, INC. Directeur/Membre du Conseil 01/01/2020
Fondateur 01/01/1989
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 01/05/2008
░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -

Anciens postes connus de Carl Gordon

SociétésPosteFin
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Carl Gordon

Formation de Carl Gordon

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

63

Relations au 1er degré

62

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées62

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Finance

Finance

Finance

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

X4 Pharmaceuticals (Austria) GmbH

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Carl Gordon
🔇